{"product_id":"advances-surgery-2026","title":"Advances in Surgery, 2026","description":"\u003ch3\u003e\u003cstrong\u003eJohn L. Cameron (Editor)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eISBN:\u003c\/strong\u003e 9780443472268\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublished:\u003c\/strong\u003e August 12, 2026\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFormat:\u003c\/strong\u003e Hardcover\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublisher:\u003c\/strong\u003e Elsevier\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eDescription\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eAdvances in Surgery, 2026 reviews the year's most significant developments across general and subspecialty surgery for the long-running Advances in Surgery series. Led by John L. Cameron, The Alfred Blalock Distinguished Service Professor of Surgery at The Johns Hopkins Medical Institutions, a distinguished editorial board commissions original articles from specialists on areas of major progress and controversy in the field. Nineteen peer-reviewed articles connect new evidence on colorectal, breast, vascular, endocrine, and abdominal wall surgery to its everyday effect on patient outcomes, giving practicing surgeons a single, current reference for clinical decision-making.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eKey Features\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e- Head-to-head comparisons that inform same-week clinical decisions: robotic versus laparoscopic colectomy for cancer, and bypass versus endovascular therapy for chronic limb-threatening ischemia.\u003cbr\u003e- A dedicated chapter on surgery in patients taking glucagon-like peptide-1 (GLP-1) receptor agonists, addressing a patient population surgical teams now encounter routinely in elective cases. \u003ca href=\"https:\/\/clnzbooks.com\/blogs\/news\/glp1-surgery-advances-2026\" style=\"color: #8b0000; text-decoration: underline; font-weight: bold;\"\u003eRead our blog post on GLP-1 and surgery\u003c\/a\u003e.\u003cbr\u003e- Practical guidance on active surveillance versus surgery for low-risk, well-differentiated thyroid cancer, and on the safety of \"watch and wait\" after complete clinical response in rectal cancer.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eCoverage\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e- Colorectal and rectal cancer surgery: timing of resection, watch-and-wait protocols, and total neoadjuvant therapy for locally advanced disease\u003cbr\u003e- Breast surgery: omission of axillary surgery in low-risk disease and management of rare breast sarcoma\u003cbr\u003e- Vascular, endocrine, and abdominal wall surgery: chronic limb-threatening ischemia, thyroid cancer surveillance, and minimally invasive abdominal wall reconstruction\u003cbr\u003e- Perioperative care: anticoagulation timing after major trauma and management of patients on GLP-1 receptor agonists\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eAbout the Editor\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eJohn L. Cameron, MD, is the Alfred Blalock Distinguished Service Professor in the Department of Surgery at The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. A past president of the American Surgical Association and the American College of Surgeons, he has edited the Advances in Surgery series for decades, drawing on an editorial board of specialists who identify the year's most clinically significant surgical literature.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eTable of Contents\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e1. Robotic versus Laparoscopic Colectomy for Cancer\u003cbr\u003e2. Management of Acute Diverticulitis: Role of Minimally Invasive Surgery versus Nonoperative Management\u003cbr\u003e3. Which Is Preferable for Chronic Limb-threatening Ischemia: Bypass versus Endovascular Therapy?\u003cbr\u003e4. Omission of Axillary Surgery for Low-Risk Breast Cancer\u003cbr\u003e5. Current Management of Extremity Lymphedema\u003cbr\u003e6. Neoadjuvant Therapy for Melanoma\u003cbr\u003e7. Myths and Science: Understanding the Current Landscape of Lymphatic Surgery\u003cbr\u003e8. Active Surveillance Versus Surgery for Low-risk Well-differentiated Thyroid Cancer\u003cbr\u003e9. Sarcoma of the Breast: A Rare and Heterogeneous Entity\u003cbr\u003e10. What Do Population-based Studies Tell Us about the Ideal Timing of Surgical Resection for Colorectal Cancer?\u003cbr\u003e11. When Should Anticoagulation Be Started after Major Trauma?\u003cbr\u003e12. Is Pyloroplasty Necessary During Esophagectomy? Review of Literature and Technical Considerations\u003cbr\u003e13. Minimally Invasive Approaches to Complex Abdominal Wall Reconstruction\u003cbr\u003e14. Do Surgical Patients Feel They Are Adequately Informed of Decision-making Prior to Surgery?\u003cbr\u003e15. Management of Serous Cystadenoma\u003cbr\u003e16. Management of Anastomotic Leaks: Endoscopic, Interventional, and Surgical Strategies\u003cbr\u003e17. Watch and Wait in Patients with Clinical Complete Response After Neoadjuvant Therapy with Rectal Cancer: Is it Safe?\u003cbr\u003e18. Surgery on Patients Taking Glucagon-Like Peptide-1 Receptor Agonists\u003cbr\u003e19. Total Neoadjuvant Therapy for the Treatment of Locally Advanced Rectal Cancer\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eWhy buy this book?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eAdvances in Surgery, 2026 distills a year of surgical literature into nineteen focused reviews, saving surgeons and surgical librarians the time of tracking primary sources across a dozen journals. Its emphasis on head-to-head comparisons (robotic vs. laparoscopic, bypass vs. endovascular) and on fast-moving perioperative questions, such as managing patients on GLP-1 receptor agonists, makes it a practical one-volume update for departments and institutions that need to stay current on evolving standards of surgical care.\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/clnzbooks.com\/collections\/medicine\" style=\"color: #8b0000; text-decoration: underline; font-weight: bold;\"\u003eBrowse more titles in our Medicine collection\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eKeywords\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eadvances in surgery 2026, John L. Cameron, surgical oncology, colorectal surgery, GLP-1 receptor agonists surgery, vascular surgery, breast surgery, perioperative medicine, abdominal wall reconstruction, thyroid cancer surgery\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eGeneral and colorectal surgeons, vascular surgeons, breast surgeons, surgical residents and fellows, academic medical libraries, hospital libraries\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eGenre\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eSurgery, Surgical Reference, Clinical Medicine\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWhat does Advances in Surgery, 2026 cover?\u003c\/strong\u003e\u003cbr\u003eIt covers nineteen original review articles on the year's most significant developments in colorectal, breast, vascular, endocrine, and abdominal wall surgery, along with perioperative topics such as anticoagulation timing and management of patients on GLP-1 receptor agonists.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWho edits the Advances in Surgery series?\u003c\/strong\u003e\u003cbr\u003eThe series is edited by John L. Cameron, MD, The Alfred Blalock Distinguished Service Professor of Surgery at The Johns Hopkins Medical Institutions, with a distinguished editorial board of surgical specialists.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes this edition address perioperative management of patients taking GLP-1 receptor agonists like semaglutide?\u003c\/strong\u003e\u003cbr\u003eYes. Chapter 18, \"Surgery on Patients Taking Glucagon-Like Peptide-1 Receptor Agonists,\" reviews the clinical considerations for this now-common patient population in elective surgery. For more context, see our \u003ca href=\"https:\/\/clnzbooks.com\/blogs\/news\/glp1-surgery-advances-2026\" style=\"color: #8b0000; text-decoration: underline; font-weight: bold;\"\u003eblog post on GLP-1 and surgery\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs Advances in Surgery, 2026 suitable for surgical training programs and libraries?\u003c\/strong\u003e\u003cbr\u003eYes. Its concise, clinically focused chapters make it a practical addition to surgical residency curricula and to academic and hospital library collections supporting surgical departments.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhere can I buy Advances in Surgery, 2026?\u003c\/strong\u003e\u003cbr\u003eYou can order Advances in Surgery, 2026 directly from CLNZ Books, with worldwide shipping included and secure payment via credit card or PayPal.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003e📘 Learn more about shipping, delivery times, and returns, see our \u003ca href=\"https:\/\/clnzbooks.com\/pages\/faq-frequently-asked-questions\" style=\"color: #8b0000; text-decoration: underline; font-weight: bold;\"\u003eFAQ here\u003c\/a\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003cstrong\u003e📦 New to ordering with us? See our \u003ca href=\"https:\/\/clnzbooks.com\/pages\/how-to-order\" style=\"color: #8b0000; text-decoration: underline; font-weight: bold;\"\u003eHow to Order\u003c\/a\u003e guide for payment, shipping, and institutional order options.\u003c\/strong\u003e\u003c\/h3\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":67777459781706,"sku":"9780443472268","price":304.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0287\/7351\/5338\/files\/Brain_Drug_1_8cc078df-09db-49fd-afac-146636166e52.jpg?v=1792680570","url":"https:\/\/clnzbooks.com\/products\/advances-surgery-2026","provider":"CLNZ Books ","version":"1.0","type":"link"}